Aortic valve replacement with new-generation stentless pericardial valves: Short-term clinical and hemodynamic results

Journal of Heart Valve Disease

Volumn 14, Issue 5, 2005, Pages 623-629

  Grubitzsch, Herko ^a   Linneweber, Jörg ^a   Kossagk, Christopher ^a   Sanli, Elif ^a   Beholz, Sven ^a   Konertz, Wolfgang F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

AGED; AORTA VALVE REPLACEMENT; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CAUSE OF DEATH; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOPPLER ECHOCARDIOGRAPHY; FATALITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PERICARDIUM; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PREOPERATIVE EVALUATION; PRESSURE GRADIENT; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; RETREATMENT; SEPSIS; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANIMALS; AORTIC VALVE STENOSIS; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CATTLE; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMIC PROCESSES; HORSES; HUMANS; MALE; PERICARDIUM; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; STENTS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 27744593979     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. David TE, Pollick C, Bos J. Aortic valve replacement with stentless porcine aortic bioprosthesis. J Thorac Cardiovasc Surg 1990;99:113-118
2. Del Rizzo DF, Goldman BS, Christakis GT, David TE. Hemodynamic benefits of the Toronto stentless valve. J Thorac Cardiovasc Surg 1996;112:143-145
3. Walther T, Falk V, Langebartels G, et al. Prospectively randomized evaluation of stentless versus conventional biological aortic valves: Impact on early regression of left ventricular hypertrophy. Circulation 1999;100(Suppl.II):II6-II10
4. Stacchino C, Bona G, Rinaldi S, Vallana F. Design and performance characteristics of the Pericarbon stentless valve. J Heart Valve Dis 1995;4(Suppl.I):102-115
5. Stacchino C, Bona G, Bonetti F, Rinaldi S, Della Ciana L, Grignani A. Detoxification process for glutaraldehyde-treated bovine pericardium: Biological, chemical, and mechanical characterization. J Heart Valve Dis 1998;7:190-194
6. Mueller XM, von Segesser LK. A new equine pericardial stentless valve. J Thorac Cardiovasc Surg 2003;125:1405-1411
7. Rubay JE, Khoury GEI, Buche M. Aortic valve replacement with the stentless bovine pericardial valve: Early experience with the Sorin valve. In: Huysmans H, David T, Westaby S (ed.). Stentless bioprostheses, 2nd edn. ISIS Medical Media, Oxford, 1999:47-52
8. Jin XY, Westaby S. Pericardial and porcine stentless aortic valves: Are they hemodynamically different? Ann Thorac Surg 2001;71:311-314
9. Bonacchi M, Giunti G, Prifti E, et al. Early postoperative outcome and hemodynamic performance of the Sorin Pericarbon stentless aortic valve. J Heart Valve Dis 2002;11:703-709
10. Nagy ZL, Bodi A, Len A, Balogh I, Peterffy A. Three years' experience with the Sorin Pericarbon stentless prosthesis: Mid-term results with three different implantation techniques. J Heart Valve Dis 2005;14:72-77
11. Doss M, Martens S, Wood JP, et al. Aortic leaflet replacement with the new 3F stentless aortic bioprosthesis. Ann Thorac Surg 2005;79:682-685
12. Beholz S, Grubitzsch H, Dushe S, Liu J, Dohmen PM, Konertz W. Impact of implantation technique on hemodynamic results of the Pericarbon Freedom stentless valve. Thorac Cardiovasc Surg 2005;53:212-216.
13. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller C, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-935
14. Westaby S, Jonson A, Payne N, et al. Does the use of a stentless bioprosthesis increase surgical risk? Semin Thorac Cardiovasc Surg 2001;13:143-147
15. Orsinelli DA, Aurigemma GP, Battista S, Krendel S, Gaasch WH. Left ventricular hypertrophy after aortic valve replacement for aortic stenosis. A high-risk subgroup identified by preoperative relative wall thickness. J Am Coll Cardiol 1993;22:1679-1683
16. Florath I, Rosendahl UP, Mortasawi A, et al. Current determinants of operative mortality in 1400 patients requiring aortic valve replacement. Ann Thorac Surg 2003;76:75-83
17. Walther T, Falk V, Rauch T, Diegeler A, Autschbach A, Mohr FW. Discrepancies of sizers for conventional and stentless aortic valve implants. J Heart Valve Dis 1997;6:145-148
18. Pibarot P, Dumesnil JG. Hemodynamic and clinical impact of prostheses-patient mismatch in the aortic valve position and its prevention. J Am Coll Cardiol 2000;36:1131-1141